- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | FDA clears sleep apnoea feature for new Apple Watch | ||
| Di | Trial sets up filings for Boehringer IPF drug nerandolimast | ||
| Di | ESMO: Pfizer drug helps cancer patients gain weight | ||
| Mo | ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer | ||
| Mo | ESMO: NIAGARA backs Imfinzi in bladder cancer, but will FDA? | ||
| Mo | Support app for young cancer patients launches in UK | ||
| Mo | AbbVie faulted for misleading ad featuring Serena Williams | ||
| Mo | ESMO: Incyte's PD-1 treads new ground in anal cancer | ||
| Fr | Syneos Health Communications takes the crown at PM Society Digital Awards | ||
| Fr | Lilly ramps up Irish manufacturing investment by $1bn | ||
| Fr | Apple AirPods get FDA okay for use as OTC hearing aids | ||
| Fr | US puts $25m behind Cellino's cell and tissue printing tech | ||
| Fr | Armed with $100m funding, F2G prepares to refile antifungal | ||
| Do | Starmer says no extra NHS funding without big reforms | ||
| Do | Moderna will cut $1.1bn off its annual R&D spend | ||
| Do | GSK drops HSV jab, leaving rival mRNA shots in pole position | ||
| Do | Dupixent delivers in two skin disease trials | ||
| Do | NHS is in "serious trouble," says Darzi report | ||
| 11.09. | Meet MILTON, AZ's AI that can predict 1,000+ diseases | ||
| 11.09. | Study backs role of Novo Nordisk obesity drug in children | ||
| 11.09. | UK doctors sceptical of AI's role in treatment | ||
| 11.09. | Roivant's new 'vant' emerges to advance Bayer lung drug | ||
| 11.09. | Viridian takes aim at Amgen's Tepezza with veligrotug data | ||
| 11.09. | In blink-and-miss-it moment, Harris vows to expand OOP cap | ||
| 10.09. | Terns files $125m financing after positive obesity data |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
